Bladder treatment preferences: patients speak out in new study

NCT ID NCT07390591

Recruiting now Knowledge-focused Sponsor: Medstar Health Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study interviews 60 adults with spinal cord injuries and neurogenic bladder, plus their caregivers, to learn about their experiences with different types of bladder washes (gentamicin, lactobacillus, or both). The goal is to understand what they like, dislike, and find helpful, so doctors can improve these treatments. Participants will have one hour-long interview about their views.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROGENIC BLADDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spinal cord injury Urinary Bladder, Neurogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROGENIC BLADDER NEUROGENIC LOWER URINARY TRACT DYSFUNCTION SPINAL CORD INJURIES

Contacts and locations

Locations

Medstar National Rehabilitation Hospital
RECRUITING

Washington D.C., District of Columbia, 20010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.